Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 11.03% is 20% above its 5-year average of 9.18%, around the middle of its 5-year range (-7.75%–23.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.27% below its 12-month average of 12.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 11.03%.
RETURN ON INVESTED CAPITAL (ROIC)
11.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
11.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-13.27%
CURRENT VS 3Y AVG
-24.54%
CURRENT VS 5Y AVG
+20.10%
CURRENT VS 10Y AVG
-5.48%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 755 covered companies
CURRENT VS SECTOR MEDIAN
+131.71%
vs the sector median at left
Lantheus Holdings, Inc.
Market Cap
$6.50B
Return on Invested Capital (ROIC)
11.03%
TTM Avg
12.71%
3Y Avg
14.61%
5Y Avg
9.18%
Market Cap
$6.49B
Return on Invested Capital (ROIC)
13.45%
TTM Avg
11.53%
3Y Avg
6.80%
5Y Avg
5.48%
Market Cap
$6.57B
Return on Invested Capital (ROIC)
-4.30%
TTM Avg
9.38%
3Y Avg
-2.79%
5Y Avg
-9.92%
Market Cap
$6.55B
Return on Invested Capital (ROIC)
-76.00%
TTM Avg
-62.20%
3Y Avg
-56.39%
5Y Avg
-47.69%
Market Cap
$6.66B
Return on Invested Capital (ROIC)
19.48%
TTM Avg
18.99%
3Y Avg
19.98%
5Y Avg
22.15%
Market Cap
$6.25B
Return on Invested Capital (ROIC)
-63.96%
TTM Avg
-73.62%
3Y Avg
-66.48%
5Y Avg
-67.69%
Market Cap
$6.02B
Return on Invested Capital (ROIC)
-20.26%
TTM Avg
-47.02%
3Y Avg
-56.93%
5Y Avg
-48.62%
Market Cap
$7.00B
Return on Invested Capital (ROIC)
2.12%
TTM Avg
16.37%
3Y Avg
14.48%
5Y Avg
9.33%
Market Cap
$5.94B
Return on Invested Capital (ROIC)
3.91%
TTM Avg
0.53%
3Y Avg
0.65%
5Y Avg
2.31%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | $6.50B | 11.03% | 12.71% | 14.61% | 9.18% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 13.45% | 11.53% | 6.80% | 5.48% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.57B | -4.30% | 9.38% | -2.79% | -9.92% |
| Immunovant, Inc. (IMVT)vs › | $6.55B | -76.00% | -62.20% | -56.39% | -47.69% |
| Chemed Corporation (CHE)vs › | $6.66B | 19.48% | 18.99% | 19.98% | 22.15% |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.25B | -63.96% | -73.62% | -66.48% | -67.69% |
| GRAIL Inc. (GRAL)vs › | $6.02B | -20.26% | -47.02% | -56.93% | -48.62% |
| Alkermes plc (ALKS)vs › | $7.00B | 2.12% | 16.37% | 14.48% | 9.33% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.94B | 3.91% | 0.53% | 0.65% | 2.31% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | -37.26% | -50.97% | -60.09% | -54.48% |
ROIC
11.0%
ROE
21.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 11.03% |
| 2026-03-31 | 10.75% |
| 2025-12-31 | 12.19% |
| 2025-09-30 | 12.44% |
| 2025-06-30 | 17.16% |
| 2025-03-31 | 17.86% |
| 2024-12-31 | 18.77% |
| 2024-09-30 | 19.44% |
| 2024-06-30 | 20.88% |
| 2024-03-31 | 23.09% |
| 2023-12-31 | 19.79% |
| 2023-09-30 | 4.12% |
| 2023-06-30 | 2.44% |
| 2023-03-31 | -2.99% |
| 2022-12-31 | 3.37% |
| 2022-09-30 | 13.03% |
| 2022-06-30 | 4.93% |
| 2022-03-31 | -2.28% |
| 2021-12-31 | -7.75% |
| 2021-09-30 | -3.33% |
| 2021-06-30 | -2.13% |
| 2021-03-31 | 0.54% |
| 2020-12-31 | -0.52% |
| 2020-09-30 | 1.07% |
| 2020-06-30 | 2.75% |
| 2020-03-31 | 12.10% |
| 2019-12-31 | 14.76% |
| 2019-09-30 | 14.10% |
| 2019-06-30 | 15.49% |
| 2019-03-31 | 13.63% |
| 2018-12-31 | 13.53% |
| 2018-09-30 | 15.22% |
| 2018-06-30 | 14.69% |
| 2018-03-31 | 15.73% |
| 2017-12-31 | 15.26% |
| 2017-09-30 | 21.03% |
| 2017-06-30 | 22.12% |
| 2017-03-31 | 21.81% |
| 2016-12-31 | 24.81% |
| 2016-09-30 | 24.28% |
| 2016-06-30 | 23.11% |
| 2016-03-31 | 22.05% |
| 2015-12-31 | 20.22% |
| 2015-09-30 | 20.38% |
| 2015-06-30 | 18.87% |
| 2015-03-31 | 11.22% |
| 2014-12-31 | 18.86% |
| 2014-09-30 | 12.65% |
| 2014-06-30 | 5.84% |
| 2014-03-31 | -0.56% |
| 2013-12-31 | -8.84% |
| 2013-09-30 | -7.30% |
